Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation, Graft-Versus-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01926899
What this trial is testing

Phase I Study Evaluating the Addition of Bortezomib to an Established Acute Graft Versus Host Disease Prophylaxis Regimen in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients

Who this might be right for
Hematopoetic Stem Cell Transplant
Indiana University 15
Testing effectiveness (Phase 2)Study completedNCT02749084
What this trial is testing

Multiple Donor Treg DLI for Severe Refractory Chronic GVHD

Who this might be right for
Chronic Graft Versus Host Disease
Mario Arpinati 18
Early research (Phase 1)Ended earlyNCT04328714
What this trial is testing

Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease

Who this might be right for
Acute LeukemiaMyelodysplastic Syndromes
Edwin Horwitz 4
Large-scale testing (Phase 3)Study completedNCT01188798
What this trial is testing

Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelocytic LeukemiaChronic Myelocytic Leukemia+2 more
St. Jude Children's Research Hospital 6
Testing effectiveness (Phase 2)Study completedNCT03434704
What this trial is testing

Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole

Who this might be right for
Transplant-Related Hematologic MalignancyLeukemia, AcuteMyelodysplastic Syndromes+2 more
Ciceri Fabio 10
Testing effectiveness (Phase 2)Study completedNCT00379587
What this trial is testing

Rituximab for Prevention of Chronic GVHD

Who this might be right for
Hematological Malignancies
Dana-Farber Cancer Institute 65
Early research (Phase 1)Temporarily pausedNCT03467386
What this trial is testing

Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
City of Hope Medical Center 56
Not applicableLooking for participantsNCT03555851
What this trial is testing

Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy

Who this might be right for
Leukemia, Not Otherwise SpecifiedLeukemia, Other
Wake Forest University Health Sciences 120
Testing effectiveness (Phase 2)Ended earlyNCT02993783
What this trial is testing

A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Millennium Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT00006417
What this trial is testing

Modified Stem Cell Transplantation Procedure for Treating Chronic Granulomatous Disease

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 10
Not applicableStudy completedNCT00053157
What this trial is testing

Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more
Roswell Park Cancer Institute 10
Testing effectiveness (Phase 2)UnknownNCT04688021
What this trial is testing

A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.

Who this might be right for
LeukemiaGraft-versus-host-disease
Yi Luo 46
Not applicableEnrolling By InvitationNCT06864598
What this trial is testing

The Application of Novel Identified CD8 Regulatory Precursors in Inducing Immune Tolerance After Allo-HSCT

Who this might be right for
Graft-versus-host Disease (GVHD)
Peking University People's Hospital 100
Not applicableActive Not RecruitingNCT04044365
What this trial is testing

Pediatric cGVHD Symptom Scale

Who this might be right for
Graft vs Host Disease
National Cancer Institute (NCI) 139
Testing effectiveness (Phase 2)Study completedNCT00201799
What this trial is testing

Infliximab for the Prevention of Graft-versus-Host Disease Following Allogenic Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft-Versus-Host Disease
Ohio State University Comprehensive Cancer Center 19
Large-scale testing (Phase 3)Active Not RecruitingNCT05153226
What this trial is testing

GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG

Who this might be right for
Graft Vs Host DiseasePeripheral Blood Stem Cell TransplantationAML+3 more
DKMS gemeinnützige GmbH 640
Testing effectiveness (Phase 2)UnknownNCT02478424
What this trial is testing

Extended Use of Cannabidiol for the Prevention of Graft-versus-host-disease

Who this might be right for
Graft vs Host Disease
Rabin Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT02133924
What this trial is testing

Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease

Who this might be right for
Acute Graft Versus Host Disease
John Levine 76
Not applicableStudy completedNCT00619879
What this trial is testing

Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies

Who this might be right for
Leukemia, Myelogenous, ChronicLeukemia, Lymphoblastic, AcuteLeukemia, Myelogenous, Acute+2 more
Ann & Robert H Lurie Children's Hospital of Chicago 81
Large-scale testing (Phase 3)Study completedNCT00180089
What this trial is testing

Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation

Who this might be right for
LeukemiaGraft-Versus-Host Disease
Technische Universität Dresden 242
Next Page